ERP Solution Manager Finance
PolyPeptide is on a transformative growth journey – expanding globally, investing in new technologies, and increasing our production capacity through major site expansions and strategic projects.
As part of this journey, we are launching a global SAP S/4HANA implementation and building a new ERP organization from the ground up. We’re now looking for an experienced ERP Solution Manager Finance to join us from the beginning and take the lead in designing and delivering scalable, future-proof financial solutions across our global organization.
This is a unique opportunity to play a central role in shaping the financial backbone of our digital transformation – from solution design and stakeholder collaboration to implementation and long-term evolution.
About us
PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a specialized Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide serves a fast-growing market, offering products and services from pre-clinical through to commercial stages. Its broad portfolio reflects the opportunities in drug therapies across areas and with a large exposure to metabolic diseases, including GLP-1. Dating back to 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.
Our Values
Trust: We build and maintain trust in all our relationships – both with each other and with our customers. We support each other and work as a team.
Innovation: We are curious and driven by finding smart solutions to the challenges we face.
Excellence: We always strive to deliver high quality and adapt to meet the needs of our customers.
About the Role
The ERP Solution Manager Finance is a critical function within PolyPeptide’s global ERP program. In this role, you will serve as PolyPeptide’s lead expert and representative for all finance-related aspects of SAP S/4HANA and other global applications supporting the end-to-end finance processes (e.g., automated AP solutions).
You will act as a bridge between business functions, the ERP team, and external service partners – working closely with the ERP Solution Architect to ensure that financial solutions align with enterprise architecture and global standards.
As part of the Global IS/IT department, you will collaborate closely with global process owners, super users, QA, and IT colleagues to drive value across finance operations and ensure compliance and continuity.
Key Responsibilities
- Act as the main liaison between business stakeholders and external AMS/system integrator partners to translate finance requirements into robust SAP S/4HANA solutions.
- Oversee technical and functional aspects of SAP S/4HANA Finance modules—ensuring ongoing administration, maintenance, compliance, and regulatory alignment.
- Lead and support IT audits, documentation, and validation efforts for finance systems, including developing key documents and end-user training programs.
- Drive process improvements and manage change requests within finance operations, participating actively in governance forums such as the Change Advisory Board.
- Monitor, resolve, and proactively reduce support tickets and incidents to ensure efficient system operations and user satisfaction.
- Collaborate on global application lifecycle planning, vendor management, license monitoring, and securing business continuity during maintenance windows.
Your Profile
To succeed in this role, you bring:
- A Bachelor’s or Master’s degree in Finance, Computer Science, Information Systems, or related field.
- 5+ years of experience in SAP Finance with at least 3 years in SAP S/4HANA Finance solution architecture.
- Experience from Automated AP Solutions.
- Experience in IT solution management in the CDMO/pharmaceutical industry is a plus.
- Proven ability to lead, communicate, and build strong relationships across all organizational levels.
- Proficient in English, both speaking and writing.
As a person, you are collaborative, proactive, flexible, and thriving in dynamic environments. Strong problem-solving skills and a commitment to excellent internal service are essential for this role.
FIND THIS INTERESTING? APPLY NOW!
Are you ready to take a central role in shaping our global SAP S/4HANA Finance landscape within a dynamic and innovative pharmaceutical environment? If this role sounds interesting, we encourage you to submit your application as soon as possible. The position will be open until August 17th, 2025, but we are applying ongoing selection so do not hesitate to send us your application.
Our Global IS/IT team is primarily based in Malmö, but we also welcome applicants located near our other sites in Strasbourg, Braine, or Ambernath, provided you are within commuting distance.
For more information, please contact Dag Widell at dag.widell@polypeptide.com. Swedish applicants are welcome to contact the local union chairman for Akademikerföreningen or Unionen at +46 040-36 62 00 for support.
- Locations
- Ambernath, Braine-l'Alleud, Malmö, Strasbourg
Our Core Values
INNOVATION
- We are curious and explore new ways.
- We are also ambitious and find solutions.
EXCELLENCE
- We have a strong technical knowledge, and we deliver results
- We lead quality in everything we do
- We are adaptable and customer focused
TRUST
- We believe in teamwork and collaboration.
- We lead by example and accept responsibility
- We are transparent and we show integrity.
About PolyPeptide Group
PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.
PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide Group AG’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.